These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8259752)

  • 1. Plasma immunoglobulin, total protein and albumin levels during Norplant use by Nigerian women.
    Otolorin EQ; Adeyefa I; Konje JC; Ojengbede O; Osotimehin B; Ladipo OA
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):645-7. PubMed ID: 8259752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.
    Balogun OR
    Niger J Clin Pract; 2007 Jun; 10(2):116-9. PubMed ID: 17902502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulins, total protein and albumin levels during UniplantR use by Nigerian women.
    Adekunle AO; Okunlola MA; Arowojolu AO; Arinola O; Salimonu LS
    Afr J Med Med Sci; 2001 Dec; 30(4):265-8. PubMed ID: 14510101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate metabolism before and after Norplant removal.
    Konje JC; Odukoya OA; Otolorin EO; Ewings PD; Ladipo OA
    Contraception; 1992 Jul; 46(1):61-9. PubMed ID: 1424624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
    Brache V; Alvarez F; Faundes A; Cochon L; Thevenin F
    Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions.
    Shaaban MM; Elwan SI; el-Sharkawy MM; Farghaly AS
    Contraception; 1984 Nov; 30(5):407-12. PubMed ID: 6440736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions.
    Shamma FN; Rossi G; HajHassan L; Penzias AS; Connoly-Diamond M; Jones E; Diamond MP
    Fertil Steril; 1995 Apr; 63(4):767-72. PubMed ID: 7890060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM; Rogers PA; Affandi B
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE
    Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with Norplant at a Nigerian teaching hospital.
    Mutihir JT; Aisien AO; Ujah IA
    East Afr Med J; 2010 Nov; 87(11):456-60. PubMed ID: 23457808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norplant: subdermal implant system for long-term contraception.
    Shoupe D; Mishell DR
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
    Phemister DA; Laurent S; Harrison FN
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):175-9. PubMed ID: 7847530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.